C-reactive protein: risk marker or mediator in atherothrombosis
Their physician recommends a GLP-1 medication, and suddenly theyre wondering whether these two treatments can safely coexist
That does not mean an extra 2,000 milligrams automatically turns stored body fat into visible abs
One GLP-1 drug, known as albiglutide, which was withdrawn from the market with only a modest effect on weight loss, nonetheless reduced the rates of major adverse cardiovascular events by 22%
If more than five days have passed, skip the missed dose entirely and take your next injection on the originally scheduled day
Tirzepatide typically starts at 2.5 mg once weekly for four weeks, then increases by 2.5 mg increments every 4 weeks as tolerated, up to a maximum of 15 mg weekly